Antiretroviral drugs and therapy (ART)

Although anti-retroviral treatment (ART) is not traditionally considered a central concern in the harm reduction agenda, from a global public health perspective, Asian Harm Reduction Network (AHRN) believes that ART remains a very important service within a comprehensive HIV/AIDS treatment and care model.

Main objective: Retrospective cohort analysis of patients who started ARV 24 + 2 months ago and followed without viral load.

This is a presentation on Critical Issues in the Success of National ARV Treatment Programs in Asia. The presentation was made by Director Kevin Robert Frost of TREAT Asia.

Background:

• In February 2004, MSF-B started pediatric HIV/AIDS care in Takeo in collaboration with the hospital pediatric team
• Located and extended nearby the pediatric ward in the compound of Daunkeo RH, Takeo provincial town
• Staff: Hospital pediatric team + MSF-B staff

This document is a training material for a 4-day training course on counselling to support children’s adherence to antiretroviral treatment (ART).

This presentation presents the findings of a case study of drug toxicity on a woman diagnosed as HIV positive. It also outlines a suggested management plan moving forward.

This presentation aims to analyse the occurrence of stavudine (d4T) related toxicity in a large cohort of patients on highly active antiretroviral therapy (HAART).

With a view to facilitating the scaling up of access to antiretroviral therapy, and in line with a public health approach, this publication outlines recent revisions WHO has made to case definitions for surveillance of HIV and the clinical and the immunological classification for HIV-related disease.

These guidelines are based on the discussions held with health-care workers, researchers and programme managers from South-East Asia during a regional consultation organized by the World Health Organization Regional Office for South-East Asia (WHO SEARO) and the United Nations Children's Fund Regional Office for South Asia (UNICEF ROSA) in New Delhi during 2006.

Background of HBC in Cambodia:

• In 1998, joint pilot project on HBC in Phnom Penh by NCHADS, Municipal Health Department, WHO, and 8 NGO
• End of 1998, evaluation of the pilot project by NCHADS and WHO
• In 1999, expansion of HBC to Battambang province
• In 2000, evaluation on HBC service by NCHADS, Alliance/KHANAAlliance/KHANA